Strengthening adverse drug reaction reporting in Nepal

Authors

  • Nisha Jha Lecturer, Department of Clinical Pharmacology and Therapeutics, KIST Medical College, Lalitpur
  • Devendra Singh Rathore L.R. Institute of Pharmacy, Jabli-kyar, Solan
  • Pathiyil Ravi Shankar Xavier University of School of Medicine
  • Sudesh Gyawali Manipal College of Medical Sciences
  • Mohamed Azmi Hassali Associate Professor, School of Pharmaceutical Sciences, University Sains Malaysia
  • Mohammed Alshakka Assistant Professor, Department of Pharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, Aden University
  • Thamir M. Alshammri Assistant Professor, Department of Clinical Pharmacy, College of Pharmacy, University of Hail

DOI:

https://doi.org/10.3126/ajms.v6i4.11659

Keywords:

Consumers, Nepal, healthcare professionals, pharmacovigilance

Abstract

Pharmacovigilance in Nepal is still in infancy. Till date only healthcare professionals are involved and the problem of underreporting is seen. The national pharmacovigilance centre is located in the national regulatory authority of Nepal, i.e. Department of Drug Administration (DDA). Lack of adequate human resources for managing the pharmacovigilance program in Nepal has been a limitation for the growth of pharmacovigilance activities. Currently, there is neither any involvement of community pharmacists in Adverse Drug Reaction (ADR) reporting process nor any involvement of consumers for the same. This paper reviews the current status of pharmacovigilance and mentions possible benefits of involving consumers or patients in the existing pharmacovigilance program. A systematic review were conducted by searching different databases like PubMed, Google scholar, EMBASE, NepJOL, and Scopus. This study also describes the role of healthcare professionals in ADR reporting, possible reasons for underreporting of ADRs, regulatory perspectives and benefits of involving consumers in pharmacovigilance.

DOI: http://dx.doi.org/10.3126/ajms.v6i4.11659

Asian Journal of Medical Sciences Vol.6(4) 2015 9-13

Downloads

Download data is not yet available.
Abstract
1287
PDF
1538

Author Biographies

Nisha Jha, Lecturer, Department of Clinical Pharmacology and Therapeutics, KIST Medical College, Lalitpur

KIST Medical College, Department of Clinical Pharmacology and Therapeutics.

Devendra Singh Rathore, L.R. Institute of Pharmacy, Jabli-kyar, Solan

Professor, Department of Pharmacy

Pathiyil Ravi Shankar, Xavier University of School of Medicine

Professor, Department of Pharmacology

Sudesh Gyawali, Manipal College of Medical Sciences

Assistant Professor, Department of Pharmacology

Mohamed Azmi Hassali, Associate Professor, School of Pharmaceutical Sciences, University Sains Malaysia

Associate Professor, School of Pharmaceutical Sciences

Mohammed Alshakka, Assistant Professor, Department of Pharmaceutics and Clinical Pharmacy, Faculty of Pharmacy, Aden University

Assistant Professor,  Department of Pharmaceutics and Clinical Pharmacy

Thamir M. Alshammri, Assistant Professor, Department of Clinical Pharmacy, College of Pharmacy, University of Hail

Assistant Professor, Department of Clinical Pharmacy, College of Pharmacy

Downloads

Additional Files

Published

2015-01-02

How to Cite

Jha, N., Rathore, D. S., Shankar, P. R., Gyawali, S., Hassali, M. A., Alshakka, M., & Alshammri, T. M. (2015). Strengthening adverse drug reaction reporting in Nepal. Asian Journal of Medical Sciences, 6(4), 9–13. https://doi.org/10.3126/ajms.v6i4.11659

Issue

Vol. 6 No. 4 (2015)

Section

Review Articles

License

Authors who publish with this journal agree to the following terms:

  1. The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).